NEC OncoImmunity AS
NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning based software, which addresses the key knowledge gaps in the prediction of bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines. The AI technology can be used to identify optimal antigen/epitope targets for infectious disease vaccines, truly personalized cancer vaccines & T cell therapies in a clinically actionable timeframe, and also facilitate effective patient selection for cancer immunotherapy. NEC OncoImmunity AS is a subsidiary of NEC Corporation, and is based in Oslo, Norway. NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential.
Find locations served, office locations
- Business Type:
- Software vendor
- Industry Type:
- Medical Monitoring
- Market Focus:
- Globally (various continents)
NEC OncoImmunity AS has assembled a growing and experienced multidisciplinary team of bioinformaticians, software-engineers and data scientists with machine-learning expertise.